Format:
Online-Ressource (XVII, 397p. 109 illus., 19 illus. in color, digital)
Edition:
1st
ISBN:
9781441999023
Series Statement:
SpringerLink
Content:
The Science and Business of Drug Discovery is written for those who want to learn about the biopharmaceutical industry and its products whatever their level of technical knowledge. Its aim is to demystify the jargon used in drug development, but in a way that avoids over simplification and the resulting loss of key information. Each of the nineteen chapters is illustrated with figures and tables which clarify some of the more technical points being made. Also included is a drug discovery case history which draws the relevant material together into a single chapter. In recognizing that it is di
Note:
Includes bibliographical references and index
,
The Science and Businessof Drug Discovery; Preface; Acknowledgments; Contents; Chapter 1: Introduction; Part I: Background to Drug Discoveryand Development; Part II: The Drug Development Pipeline:Discovery to Testing in Humans; Part III: The Drug Development Pipeline:Clinical Trials to Marketing Authorization; Part IV:The Global Pharmaceuticals Business; Part V:Professional Interactions with the Drug Discovery Industry; Appendix 1: Further Reading; Appendix 2: Glossary and External Resources; Index;
Additional Edition:
ISBN 9781441999016
Additional Edition:
Buchausg. u.d.T. ISBN 978-1-441-99901-6
Language:
English
Keywords:
Arzneimittelentwicklung
;
Arzneimittelforschung
DOI:
10.1007/978-1-4419-9902-3
URL:
Volltext
(lizenzpflichtig)
Bookmarklink
